US 12331057
Modulators of alpha-1 antitrypsin
granted A61KA61K31/4162A61K9/1635
Quick answer
US patent 12331057 (Modulators of alpha-1 antitrypsin) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/4162, A61K9/1635, A61K9/1652, A61P